Skip To Main Content
Jiazhen Yin on Muck Rack

Jiazhen Yin

As seen in: MDPI, Cell Press, Canadian Journal of Infectious Diseases & Medical Microbiology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jiazhen

Contact Jiazhen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Impact of COVID-19 Vaccination on Cardiac Function and Survival in Maintenance Hemodialysis Patients

|
By Xiao Yu Tu, Tingfei He, Bing Xu, Jiazhen Yin
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Impact of COVID-19 Vaccination on Mortality and Clinical Outcomes in Hemodialysis Patients

|
By Rihong Hu, Jiazhen Yin, Yuxuan Zhu, Tingfei He
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future

|
By Zak M. Whiting, Jiazhen Yin, Andrea J. Vernall
| Cell Press Verified
Highlights Cannabinoid Receptor 2 (CB2) is a promising therapeutic target, particularly for inflammatory disorders and pain; however, clinical trials to date have been unsuccessful. Medicinal chemistry efforts have produced selective ligands with a wide range of core scaffolds. Optimisation for drug-like properties and oral administration has been demonstrated to be feasible, but few such compounds have been tested clinically to date.
Open in Who Shared Issue with article?
See all 3 licensed articles (4 Total)